Seroprevalence of influenza A(H1N1) pdm09 virus antibody, England, 2010 and 2011

Emerging Infectious Diseases

Volumn 18, Issue 11, 2012, Pages 1894-1897

  Hoschler, Katja ^a   Thompson, Catherine ^a   Andrews, Nick ^a   Galiano, Monica ^a   Pebody, Richard ^a   Ellis, Joanna ^a   Stanford, Elaine ^a   Baguelin, Marc ^a   Miller, Elizabeth ^a   Zambon, Maria ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; SEASONS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84867892352     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1811.120720     Document Type: Article

References (15)

1. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess. 2010;14:115-92.
2. Presanis AM, Pebody RG, Paterson BJ, Tom BD, Birrell PJ, Charlett A, et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ. 2011;343:d5408. http://dx.doi.org/10.1136/bmj.d5408
3. Health Protection Agency. Seroepidemiology Programme. London [cited 2012 May 14]. http://www.hpa.org.uk/Topics/Infectious Diseases/InfectionsAZ/SeroepidemiologyProgramme/
4. Galiano M, Agapow PM, Thompson C, Platt S, Underwood A, Ellis J, et al. Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS ONE. 2011;6:e23779. http://dx.doi. org/10.1371/journal.pone.0023779
5. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178:53-60. http://dx.doi.org/10.1086/515616
6. Viasus D, Cordero E, Rodriguez-Bano J, Oteo JA, Fernandez-Navarro A, Ortega L, et al. Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first postpandemic influenza season. Clin Microbiol Infect. 2012;18:E55-62. http://dx.doi.org/10.1111/j.1469-0691.2011.03753.x
7. Saglanmak N, Andreasen V, Simonsen L, Molbak K, Miller MA, Viboud C. Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine. 2011;29(Suppl 2):B42-8. http://dx.doi.org/10.1016/j. vaccine.2011.02.065
8. Davies JR, Grilli EA, Smith AJ. Infection with influenza A H1N1. 2. The effect of past experience on natural challenge. J Hyg (Lond). 1986;96:345-52. http://dx.doi.org/10.1017/S0022172400066092
9. Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, et al. A randomised, partially observer blind, multicentre, headto-head comparison of a two-dose regimen of Baxter and Glaxo-SmithKline H1N1 pandemic vaccines, administered 21 days apart. Health Technol Assess. 2010;14:193-334.
10. Walker WT, de Whalley P, Andrews N, Oeser C, Casey M, Michaelis L, et al. H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study. Clin Infect Dis. 2012;54:661-9. http://dx.doi.org/10.1093/cid/cir905
11. Health Protection Agency. Pandemic H1N1 (swine) influenza vaccine uptake amongst patient groups in primary care in England 2009/10 [cited 2012 May 14]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_121014.pdf
12. Health Protection Agency. Surveillance of influenza and other respiratory viruses in the UK: 2010-2011 report [cited 2012 May 14]. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296687414154
13. Health Protection Agency. Seasonal influenza vaccine uptake amongst GP patient groups in England. Winter season 2010-11 [cited 2012 May 14]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_129856.pdf
14. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18:274-80. http://dx.doi.org/10.1038/nm.2612
15. Sun S, Zhao G, Xiao W, Hu J, Guo Y, Yu H, et al. Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J. 2011;8:52. http://dx.doi. org/10.1186/1743-422X-8-52